20 years helping business leaders deliver alpha. View our success stories
20 years helping business leaders deliver alpha. View our success stories
By Humatica
As the fall-out from COVID-19 threatens to sink entire portfolios, PE sponsors and CEO’s need to walk a tightrope between preserving organisational capabilities in order to resume growth in case of a rebound in 2H 2020, while at the same time preparing to survive a protracted recession or even depression if things go wrong.
Our latest HumaticaCorner explores the options for portfolio managers and CEOs.
As the traditional levers of value creation get price-in, getting a competitive edge in private equity lies in unlocking hidden potential within portfolio companies through…
Read more
According to the most recent federal statistics, business bankruptcy filings surged by 33% in the US between September 2023 and September 2024. Elevated debt, higher supplier costs,…
Read more
CEOs envisioning a new organizational structure often face a daunting question: how do I bring this vision to life across my organization? The stakes are…
Read more
Erhalten Sie jeden Monat Neuigkeiten und wertvolle Perspektiven zu Themen der organisatorischen Effektivität
